News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
724
Sources here
24
Companies here
15
Search results Stored financial headlines

Active search

724 matching headlines

Ticker or company: DEXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Codexis, Inc. Q2 2026 Earnings Call Summary

Codexis, Inc. reported a return to growth in its pharma biocatalysis business, driven by new product approvals and a significant label expansion. The company is strategically focusing on industrializing its ECOsynthesis platform to address projected siRNA demand, backed by recent equity financing and improved …

CDXS main company
Sharemaestro market context Price below Trend Line 52 weeks -45.9% CDXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Standex International Corporati (SXI) Stock forecasts

Argus has lowered its target price for Standex International Corp (SXI) to $325.00, according to a report published on July 29, 2026. Standex International is an industrial manufacturer serving commercial and industrial markets. The current price of SXI is $333.02.

SXI main company
Sharemaestro market context Trend signal active 52 weeks +58.0% SXI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Codexis narrows Q2 loss, raises $25M to fund GMP expansion

Codexis Inc. (NASDAQ: CDXS) significantly narrowed its Q2 2026 net loss to $12.0 million and beat EPS estimates, though revenue slightly declined. The company also secured $25 million in equity financing, extending its cash runway until 2028 and enabling the expansion of its ECO …

CDXS main company
Sharemaestro market context Price below Trend Line 52 weeks -45.9% CDXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DexCom’s 37.5% quarter puts CGM maker within 3.5% of its high as volume stays moderate

DexCom closed at $84.75 after a ninth week in an active Trend Signal, but participation is only 1.1x baseline and the signal mix is balanced rather than emphatic.

DXCM main company
Sharemaestro market context Trend signal active 52 weeks +9.1% DXCM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Codexis outlines $72M-$76M 2026 revenue as it plans ~$25M GMP facility build-out

Earnings Call Insights: Codexis (CDXS) Q2 2026 MANAGEMENT VIEW * CEO Alison Moore said Codexis delivered “solid financial results for the second quarter of 2026 with revenue of $14.9 million” and highlighted that a financing “resulted in a capital raise of $25 million of …

CDXS main company
Sharemaestro market context Price below Trend Line 52 weeks -45.9% CDXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Celldex Therapeutics (CLDX) Is Up 10.7% After Wider Losses And Barzolvolimab Phase 3 Progress

Celldex Therapeutics (CLDX) reported wider Q2 and first-half losses totaling US$73.5 million and US$152.19 million, respectively, yet its stock rose by 10.7%. This increase is attributed to positive Phase 1 data for bispecific antibody CDX-622 and continued Phase 3 progress for barzolvolimab, despite minimal …

CLDX main company
Sharemaestro market context Trend signal active 52 weeks +86.8% CLDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Memphis airport renamed after late FedEx founder Frederick W. Smith

Memphis International Airport has been officially renamed Frederick W. Smith International Airport in honor of the late FedEx founder. The dedication ceremony took place on what would have been Smith's 82nd birthday, recognizing his profound impact on Memphis as a global logistics hub. The …

FDX main company
Sharemaestro market context Trend signal active 52 weeks +121.1% FDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Codexis beats Q2 2026 estimates as shares rise after hours

Codexis, Inc. reported a return to growth in its pharma biocatalysis business, driven by new product approvals and a significant label expansion. The company is strategically focusing on industrializing its ECOsynthesis platform to address projected siRNA demand, backed by recent equity financing and improved …

CDXS main company
Sharemaestro market context Price below Trend Line 52 weeks -45.9% CDXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IDEX Corp. stock outperforms competitors on strong trading day

IDEX Corp. (IEX) saw its stock rally 1.73% to $237.31 on a tough trading day for the broader market, outperforming the S&P 500 and Dow Jones Industrial Average, which both fell. The company's stock closed 2.66% below its 52-week high reached on July 29th. …

IEX main company
Sharemaestro market context Trend signal active 52 weeks +43.4% IEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Is Standex (NYSE:SXI) Gaining as NYSE Composite Sales Grow 8.1%?

The article discusses Standex International (NYSE:SXI), an industrial company operating in various technological and manufacturing sectors globally. It highlights that Standex is gaining as the NYSE Composite sales grow by 8.1% but provides limited public content, requiring users to log in or register to …

SXI main company
Sharemaestro market context Trend signal active 52 weeks +58.0% SXI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.53% on Tuesday, closing at $586.64, despite a general downturn in the stock market. The S&P 500 Index and Dow Jones Industrial Average also saw declines of 0.32% and 0.34%, respectively. The company's stock is now 23.81% below …

IDXX main company
Sharemaestro market context Price below Trend Line 52 weeks -14.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Memphis airport officially renamed Frederick W. Smith International Airport

The Memphis airport has been officially renamed Frederick W. Smith International Airport in honor of FedEx founder Fred Smith. The airport authority unanimously voted for the name change following Smith's passing last June. The airport's code, MEM, will remain the same.

FDX main company
Sharemaestro market context Trend signal active 52 weeks +121.1% FDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Codexis Reports Second Quarter 2026 Financial Results

Codexis, Inc. reported its second-quarter 2026 financial results, with total revenues of $14.9 million. The company reiterated its full-year 2026 financial guidance, projecting revenues between $72 million and $76 million. Key highlights include advancements in RNA therapeutic manufacturing, a successful equity capital raise of …

CDXS main company
Sharemaestro market context Price below Trend Line 52 weeks -45.9% CDXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Memphis International Airport officially renamed after FedEx founder

Memphis International Airport has been officially renamed Frederick W. Smith International Airport, honoring the late FedEx founder. The renaming ceremony took place on Tuesday, August 11th, with hundreds in attendance to witness the historic event. Richard Smith, FedEx Corp. senior executive and son of …

FDX main company
Sharemaestro market context Trend signal active 52 weeks +121.1% FDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full Conference Call Transcript Operator: Good morning, …

IDXX main company I1DX34 main company IDXX main company IX1 main company IDXX main company
Sharemaestro market context Price above Trend Line 52 weeks -13.7% · Next-week setup negative 32.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

IDEXX Laboratories, Inc. has launched the Catalyst™ proBNP Test, a new dual-species, in-clinic test for NT-proBNP, expanding its cardiac diagnostic capabilities. This test provides rapid, accurate quantitative cardiac assessment for cats and dogs directly at the point of care, addressing a significant need in …

IDXX main company I1DX34 main company IDXX main company IX1 main company IDXX main company
Sharemaestro market context Price above Trend Line 52 weeks -13.7% · Next-week setup negative 32.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment

IDEXX Laboratories has introduced the Catalyst proBNP Test, designed for in-clinic assessment of cardiac disease in animals. This launch is expected to enhance veterinary diagnostics by providing rapid and accurate results. The company, a leader in veterinary diagnostics, continues to innovate in the animal …

IDXX main company
Sharemaestro market context Price below Trend Line 52 weeks -14.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IDEXX Test Brings Heart-Disease Results for Cats and Dogs in Minutes

IDEXX Laboratories has launched the Catalyst™ proBNP Test, a new in-clinic diagnostic tool for heart disease in cats and dogs. This dual-species test provides quantitative NT-proBNP results in minutes, allowing veterinarians to assess cardiac health and make informed treatment decisions faster. The test expands …

IDXX main company
Sharemaestro market context Price below Trend Line 52 weeks -14.7% IDXX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context